Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?

DexCom to Roll Out Reimagined Stelo App With Global Expansion Plans

Dexcom Further Advances Vision of Glucose Biosensing for All

3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend

Living Longer Is Big Business. These Stocks Will Benefit.

3 Stocks Doing the Heavy Lifting in Healthcare's Rebound

The Healthcare M&A Wave

DXCM Receives FDA Clearance for Stelo OTC CGM System for Children

Here's Why DexCom (DXCM) is a Strong Growth Stock

FDA clears first over-the-counter glucose monitor for children

Pharmsource says it was unaware Dexcom sensors it bought were slated for destruction

Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term

DexCom Reports Positive CONNECT Data for Non-Insulin Diabetes

Clinical Wins Boost Dexcom Growth Story In Type 2 Diabetes

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

Dexcom's glucose monitor use shows benefit in non-insulin diabetic patients in study

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin

Skip the Oura Ring IPO. Buy These 10 Stocks Instead.

Here's Why You Should Retain DexCom Stock in Your Portfolio

DexCom vs. Insulet: Which Diabetes Stock Is a Better Buy in 2026?

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026

2 Growth Stocks to Buy and Hold for a Decade

Dexcom Releases Customer Advisory Council Report, Outlining Ongoing Commitments to Enhancing Product Performance and User Experience

Why DexCom (DXCM) is a Top Growth Stock for the Long-Term

Signos grows foothold in weight-loss wave fueled by GLP-1s with its AI health data tracking

Dexcom warns patients as stolen glucose sensors hit the market

Dexcom Uncovers Theft of Scrapped Product, Notifies Potentially Impacted Users

Dexcom: A Medical Platform Play Gaining From AI, Not Disrupted By It

DexCom Might Finally Be Cheap Enough

Here's Why DexCom (DXCM) is a Strong Momentum Stock

DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany

DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day

Diabetes Tech Player DexCom Lays Out 2030 Growth Vision

Here's Why DexCom (DXCM) is a Strong Value Stock

Dow, Nasdaq Futures Drop Over 400 Points as Tech Retreats

DexCom, Inc. (DXCM) Analyst/Investor Day Transcript

Dexcom to appoint two directors, revamp board committee with Elliott

Dexcom Announces Governance Enhancements Ahead of 2026 Investor Day

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Autodesk, Celanese, DexCom, FormFactor, GitLab, Lowe’s, Matador Resources, Toast and More

Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

3 Reasons Analysts Love DexCom

Dexcom to Host Investor Day on May 14, 2026

DexCom Stock Up on Q1 Earnings & Revenues Beat, Margins Rise

DexCom Inc (DXCM) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Market Expansions

DexCom, Inc. (DXCM) Q1 2026 Earnings Call Transcript

DexCom (DXCM) Q1 Earnings and Revenues Top Estimates

Dexcom reaffirms full-year forecast after topping quarterly estimates